ISSN Print 2713-0894
ISSN Online 2713-0908
BIOMEDICAL JOURNAL OF ERMC EASTERN EUROPEAN
Copyright: © 2021 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
OPINION
Drug repositioning: lessons from the COVID-19 pandemic
About authors
Orekhovich Institute of Biomedical Chemistry, Moscow, Russia
Correspondence should be addressed: Vladimir V. Poroikov
Pogodinskaya, ul., 10, Str. 8, Moscow, 119121, Russia; ur.ksm.cmbi@vokiorop.rimidalv
About paper
Acknowledgement: the study is supported by the Ministry of Science and Higher Education of the Russian Federation in the framework of the Interdepartmental Working Group on the Development of Drugs with Direct Antiviral Activity against SARS-CoV-2 (project No. 121102900156–6).
Received: 2021-10-16
Accepted: 2021-11-27
Published online: 2021-12-30
